LifeStance Health Group Inc

LifeStance Health Group Inc (LFST) Stock Analysis

$12.310

+0.010 (+0.08%)At close

Loading chart…
High
12.590
Open
12.310
VWAP
12.38
Vol
4.05M
Mkt Cap
1.87B
Low
12.235
Amount
50.08M
EV/EBITDA, TTM
23.82

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

AI analysis of LifeStance Health Group Inc (LFST)

buy

LifeStance Health Group Inc (LFST) is a good buy right now, trading at $12.31 with a strong recent performance, including a 26% year-over-year revenue growth reported in Q2 2026 and an adjusted EPS of $0.11, exceeding expectations. The forward P/E ratio is 71.43, indicating growth potential, while the RSI is at 55.20, suggesting a healthy momentum. However, insider selling has surged by 53168.39%, which is a notable risk.

Valuation Metrics

The current forward P/E ratio for LifeStance Health Group Inc (LFST) is 71.43, compared to its 5-year average forward P/E of 6.43.

Forward P/E

Fair
5Y Average P/E
6.43
Current P/E
71.43
Overvalued
102.08
Undervalued
-89.22

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
36.89
Current EV/EBITDA
23.82
Overvalued
54.37
Undervalued
19.40

Forward P/S

Fair
5Y Average P/S
2.40
Current P/S
2.40
Overvalued
3.51
Undervalued
1.30

Alphio AI Price Scenarios for LFST

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%LFST

$8.88

Scenario price

B

Base

Base · 50%LFST

$8.02

Scenario price

B

Bear

Bear · 25%LFST

$6.83

Scenario price

Whales holding LFST

T

TPG Capital, L.P.

+ HoldingLFST

+25.44%

3M Return

I

Integral Health Asset Management, LLC

+ HoldingLFST

+15.08%

3M Return

Events Timeline

2026-08-10 (ET)

12:30:00

LifeStance Stock Rises 13.2% to $12.27

2026-08-06 (ET)

07:01:00

2026 Consensus Adjusted EBITDA Forecast $215M-$235M

07:01:00

Sees Q3 Adjusted EBITDA of $49M-$59M

2026-05-07 (ET)

23:50:00

JPMorgan Prices Deal at $8.15

17:40:00

JPMorgan Acts as Sole Book Running Manager for the Offering

News

LFST FAQ — answered by Alphio AI

LifeStance Health Group, Inc. is a reimagining mental health company. The Company is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. It employs approximately 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers. It operates in the Healthcare sector (SERVICES-HEALTH SERVICES industry).

LifeStance Health Group Inc (LFST) is a good buy right now, trading at $12.31 with a strong recent performance, including a 26% year-over-year revenue growth reported in Q2 2026 and an adjusted EPS of $0.11, exceeding expectations. The forward P/E ratio is 71.43, indicating growth potential, while the RSI is at 55.20, suggesting a healthy momentum. However, insider selling has surged by 53168.39%, which is a notable risk.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started